腫瘍学における臨床応用のための多様式統合戦略
Baoyi Zhang1, Zhuoya Wan2, Yige Luo1
1AbbVie Bay Area, South San Francisco, CA, United States.
Frontiers in pharmacology
|September 5, 2025
まとめ
人工知能 (AI) は,マルチオミクスやイメージングを含む様々ながん患者のデータを統合し,包括的な洞察を得ます. このマルチモダルのアプローチは,腫瘍学における診断,予後,治療戦略を向上させます.
科学分野:
- 腫瘍学
- バイオ情報学
- 医療用イメージング
- 人工知能
背景:
- 臨床は様々な患者データ (臨床,ゲノミクス,画像) を生み出します.
- 現在の分析は,単一のデータタイプに焦点を当て,包括的な洞察を制限しています.
- マルチモダルのデータを統合することは 癌治療の進歩に不可欠です
研究 の 目的:
- 腫瘍学における高度なマルチモダルデータ統合戦略の概要を提示する.
- AI駆動のマルチモダル分析の臨床的可能性を探求する.
- 課題や将来の方向性を議論する
主な方法:
- 単一のデータ処理方法:マルチオミック,イメージング,臨床ノート
- 機械学習 表現学習 視覚言語モデル
- 多様性統合戦略の策定,強みと弱みについて
主要な成果:
- AIは複雑で異質な癌のデータを 効率的に統合できます
- マルチモダルの分析は,単一モダルのアプローチよりも深い洞察を提供します.
- 特定のデータ型と統合に合わせた AI 方法を特定した.
結論:
- マルチモダルのAI統合は癌の早期発見と診断に 大きな可能性を秘めています
- バイオマーカーの発見と臨床結果の予測を容易にする.
- 腫瘍学における現在の課題と将来の研究方向性を概説しています.
関連する概念動画
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Nursing Clinical Information System
860
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
860
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


